![logo](/logos/SANA.webp)
Sana Biotechnology, Inc.
NASDAQ:SANA
5.04 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Sana Biotechnology, Inc. |
Symbool | SANA |
Munteenheid | USD |
Prijs | 5.04 |
Beurswaarde | 1,121,228,640 |
Dividendpercentage | 0% |
52-weken bereik | 2.745 - 12 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Steven D. Harr M.D. |
Website | https://www.sana.com |
An error occurred while fetching data.
Over Sana Biotechnology, Inc.
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others. Its product candidates include SG295
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)